Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#121 / 200 Total
BZFD - BuzzFeed Inc - Stock Price Chart
TickerBZFD [NASD]
CompanyBuzzFeed Inc
CountryUSA
IndustryInternet Content & Information
Market Cap100.90MEPS (ttm)-1.86
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.42EPS next 5Y47.50%
P/B1.48EPS Q/Q74.21%
Dividend-Sales Q/Q-39.75%
Insider Own55.93%Inst Own7.32%
Insider Trans-13.44%Inst Trans12.03%
Short Float6.43%EarningsAug 12/a
Analyst Recom3.00Target Price4.00
Avg Volume707.22K52W Range0.64 - 4.56
Aug-12-24 04:19PM BuzzFeed, Inc. Posts Strong Q2 Financial Results and Expects Continued Improvement in Q3 (Business Wire) +25.89%
Jul-16-24 05:08PM Pulte Family Is Betting Big on BuzzFeed Stock. They Want to See Change, Too. (InvestorPlace)
Jul-11-24 04:30PM BuzzFeed, Inc. to Release Second Quarter 2024 Financial Results on Monday, August 12, 2024 (Business Wire)
Jun-28-24 03:34PM 3 Stocks to Buy Instead of DJT as Trump Media Keeps Falling (InvestorPlace) -5.48%
Jun-27-24 10:05AM The 7 Smartest Stocks to Buy With $100 Right Now (InvestorPlace) -8.18%
Jun-24-24 04:09PM BuzzFeed wants to sell Hot Ones to pay off its debts (Quartz) +23.47%
11:27AM Vivek Ramaswamy Just Upped His Bet on BuzzFeed (BZFD) Stock (InvestorPlace)
Jun-20-24 07:15AM 7 Underestimated Stocks Poised for an Underdog Uprising (InvestorPlace)
Jun-18-24 02:30PM 7 Stocks to Buy Now: June 2024 (InvestorPlace)
06:30AM Faraday Future (FFIE) Stock: To the Moon or Straight to Zero? (InvestorPlace)
CMMB - Chemomab Therapeutics Ltd ADR - Stock Price Chart
TickerCMMB [NASD]
CompanyChemomab Therapeutics Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap25.63MEPS (ttm)-1.14
P/E-EPS this Y-181.55%
Forward P/E-EPS next Y5.75%
PEG-EPS past 5Y37.62%
P/S-EPS next 5Y-
P/B2.57EPS Q/Q64.42%
Dividend-Sales Q/Q-
Insider Own15.76%Inst Own11.50%
Insider Trans0.00%Inst Trans-0.56%
Short Float1.78%EarningsAug 21/b
Analyst Recom1.00Target Price8.67
Avg Volume233.42K52W Range0.42 - 2.55
Aug-28-24 07:00AM Chemomab Therapeutics to Present at September 2024 Investor Conferences (GlobeNewswire) +12.73%
Aug-21-24 07:00AM Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-12-24 07:00AM Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update (GlobeNewswire)
Jul-30-24 09:00AM Chemomab Therapeutics Announces Closing of $10 Million Private Placement (GlobeNewswire)
Jul-26-24 07:00AM Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement (GlobeNewswire) +6.72%
Jul-25-24 07:38AM Chemomab Therapeutics Announces $10 Million Private Placement (GlobeNewswire) -16.20%
07:00AM Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis (GlobeNewswire)
Jun-27-24 12:00PM Chemomab Therapeutics (CMMB) Upgraded to Buy: Here's What You Should Know (Zacks)
Jun-18-24 07:00AM Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis (GlobeNewswire) +11.54%
Jun-06-24 07:00AM Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference (GlobeNewswire) -11.64%
STAF - Staffing 360 Solutions Inc - Stock Price Chart
TickerSTAF [NASD]
CompanyStaffing 360 Solutions Inc
CountryUSA
IndustryStaffing & Employment Services
Market Cap1.42MEPS (ttm)-7.81
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-28.00%
P/S0.01EPS next 5Y-
P/B-EPS Q/Q-359.73%
Dividend-Sales Q/Q-28.84%
Insider Own28.82%Inst Own9.17%
Insider Trans0.00%Inst Trans-
Short Float12.19%EarningsAug 13
Analyst Recom1.00Target Price10.00
Avg Volume1.39M52W Range1.08 - 7.60
Aug-12-24 05:38PM Staffing 360: Q2 Earnings Snapshot (Associated Press Finance) +8.79%
Jul-11-24 07:29AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jul-09-24 12:00PM What Makes Staffing 360 (STAF) a New Buy Stock (Zacks)
Jun-24-24 09:00AM Staffing 360 Solutions Announces Reverse Stock Split (GlobeNewswire) -27.96%
May-28-24 04:05PM Staffing 360 Solutions Receives Nasdaq Notification Related to Non-Timely Filing of 2024 First Quarter Form 10-Q (GlobeNewswire) +5.74%
Apr-23-24 08:05AM Staffing 360 Solutions Receives Nasdaq Notification Related to Non-Timely Filing of its 2023 Form 10-K (GlobeNewswire)
Feb-15-24 04:15PM Staffing 360 Solutions Shifts Strategy to Focus Exclusively on U.S. Staffing Industry; Divests U.K. Staffing Business (GlobeNewswire) +13.61%
Feb-07-24 08:05AM Several Staffing 360 Solutions Brands Receive Awards for Exceptional Client Service (GlobeNewswire) -5.92%
Jan-10-24 08:05AM Staffing 360 Solutions Reports Third Quarter and Nine-Month 2023 Financial Results (GlobeNewswire)
Jan-09-24 04:25PM Staffing 360: Q3 Earnings Snapshot (Associated Press Finance) +6.88%
ASTS - AST SpaceMobile Inc - Stock Price Chart
TickerASTS [NASD, RUT]
CompanyAST SpaceMobile Inc
CountryUSA
IndustryCommunication Equipment
Market Cap4.71BEPS (ttm)-1.26
P/E-EPS this Y0.86%
Forward P/E-EPS next Y32.88%
PEG-EPS past 5Y-80.78%
P/S3367.38EPS next 5Y-
P/B30.55EPS Q/Q-111.13%
Dividend-Sales Q/Q-
Insider Own14.86%Inst Own34.87%
Insider Trans0.02%Inst Trans-1.19%
Short Float17.43%EarningsAug 14/a
Analyst Recom1.17Target Price37.98
Avg Volume16.09M52W Range1.97 - 39.08
Sep-12-24 04:00PM AST SpaceMobile launches first commercial satellites (Yahoo Finance Video) +11.35%
09:10AM AST SpaceMobile Announces Successful Orbital Launch of Its First Five Commercial Satellites (Business Wire)
Sep-04-24 08:41AM AST SpaceMobile Provides Interim Business Update to Confirm Upcoming Orbital Launch and Warrant Redemption (Business Wire) +12.48%
Aug-28-24 08:00AM AST SpaceMobile Announces Redemption of Public Warrants (Business Wire) -10.41%
Aug-20-24 09:32PM Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer (CNBC TV) -11.09% +6.18%
Aug-16-24 09:00AM AST SpaceMobile Offers Retail Shareholders a Chance to Attend the BlueBird 1-5 Launch (Business Wire)
Aug-15-24 01:40PM AST SpaceMobile Shares Soar as Inaugural Launch Approaches (The Wall Street Journal) +50.70%
Aug-14-24 04:30PM AST SpaceMobile Provides Business Update and Second Quarter 2024 Results (Business Wire)
Aug-08-24 04:30PM AST SpaceMobiles Commercial Satellites Arrive at Cape Canaveral For Upcoming Launch (Business Wire) +13.65%
Aug-05-24 07:15AM FCC Approves AST SpaceMobile Launch of First Commercial Satellites, Each the Largest-Ever Communications Array to be Deployed Commercially in Low Earth Orbit (Business Wire)
FULC - Fulcrum Therapeutics Inc - Stock Price Chart
TickerFULC [NASD, RUT]
CompanyFulcrum Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap198.43MEPS (ttm)-0.35
P/E-EPS this Y81.92%
Forward P/E-EPS next Y-363.77%
PEG-EPS past 5Y1.09%
P/S2.43EPS next 5Y16.40%
P/B0.72EPS Q/Q326.40%
Dividend-Sales Q/Q8990.91%
Insider Own7.48%Inst Own84.26%
Insider Trans-0.01%Inst Trans26.12%
Short Float13.96%EarningsJul 31/b
Analyst Recom2.44Target Price6.86
Avg Volume1.47M52W Range2.87 - 13.70
Sep-13-24Downgrade H.C. Wainwright Buy → Neutral $17 → $4
Sep-13-24 04:30PM Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.56%
Sep-12-24 11:32AM Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial (Benzinga) -61.13%
08:10AM Fulcrum shares collapse as Sanofi-partnered muscular dystrophy drug fails key test (BioPharma Dive)
06:55AM Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) (GlobeNewswire)
Sep-09-24 02:28PM Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease (Benzinga)
Aug-27-24 04:05PM Fulcrum Therapeutics to Participate in Upcoming September Conferences (GlobeNewswire) -9.09%
Aug-23-24 04:30PM Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.22%
Aug-21-24 09:55AM Wall Street Analysts Believe Fulcrum Therapeutics (FULC) Could Rally 71.02%: Here's is How to Trade (Zacks)
Aug-19-24 07:00AM Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer (GlobeNewswire)
Aug-09-24 04:30PM Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
DRUG - Bright Minds Biosciences Inc - Stock Price Chart
TickerDRUG [NASD]
CompanyBright Minds Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap5.69MEPS (ttm)-0.68
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-137.36%
P/S-EPS next 5Y-
P/B1.28EPS Q/Q112.54%
Dividend-Sales Q/Q-
Insider Own35.48%Inst Own4.22%
Insider Trans0.00%Inst Trans-
Short Float6.30%Earnings-
Analyst Recom1.00Target Price45.46
Avg Volume106.96K52W Range0.93 - 2.39
Sep-12-24 08:00AM Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy (PR Newswire)
Aug-12-24 07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
May-20-24 11:53AM DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q2 2024 (InvestorPlace)
Dec-06-23 05:08PM Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management (PR Newswire) +5.53%
Aug-08-23 06:50AM Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101 (GlobeNewswire) +29.50%
Jul-20-23 06:50AM Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101 (GlobeNewswire) -16.38%
Jul-11-23 06:50AM Bright Minds Announces Effective Date of Share Consolidation (GlobeNewswire)
Jun-22-23 06:50AM Bright Minds Announces Proposed Share Consolidation (GlobeNewswire) +5.33%
Apr-19-23 06:50AM Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202 (GlobeNewswire) +26.08%
Apr-10-23 06:50AM Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research (GlobeNewswire)
DRMA - Dermata Therapeutics Inc - Stock Price Chart
TickerDRMA [NASD]
CompanyDermata Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.09MEPS (ttm)-27.47
P/E-EPS this Y61.95%
Forward P/E-EPS next Y74.61%
PEG-EPS past 5Y26.37%
P/S-EPS next 5Y-
P/B0.33EPS Q/Q55.68%
Dividend-Sales Q/Q-
Insider Own2.04%Inst Own2.49%
Insider Trans0.00%Inst Trans-96.89%
Short Float1.75%EarningsAug 07/a
Analyst Recom1.00Target Price6.00
Avg Volume2.19M52W Range1.29 - 17.55
Sep-05-24 04:05PM Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 (ACCESSWIRE) -5.30% +10.49%
Aug-07-24 11:53PM DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024 (InvestorPlace) +12.45%
04:05PM Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results (ACCESSWIRE)
Jul-17-24 09:00AM Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne (ACCESSWIRE)
May-17-24 08:30AM Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE) -19.23%
May-15-24 10:54PM DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024 (InvestorPlace) +5.05%
04:05PM Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results (ACCESSWIRE)
May-13-24 07:23AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +5.94%
Apr-03-24 07:00AM Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire)
Apr-02-24 07:00AM Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
ESLA - Estrella Immunopharma Inc - Stock Price Chart
TickerESLA [NASD]
CompanyEstrella Immunopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap39.65MEPS (ttm)-0.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.69EPS Q/Q51.47%
Dividend-Sales Q/Q-
Insider Own75.60%Inst Own0.34%
Insider Trans0.00%Inst Trans0.09%
Short Float0.22%Earnings-
Analyst Recom-Target Price-
Avg Volume94.70K52W Range0.81 - 20.80
Aug-14-24 12:00PM Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member (Business Wire)
Aug-02-24 07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -18.08%
May-20-24 10:52AM ESLA Stock Earnings: Estrella Immunopharma Reported Results for Q3 2024 (InvestorPlace)
Sep-29-23 10:34AM TradeUP Acquisition Corp. and Estrella Biopharma, Inc. Announce Completion of Business Combination (PR Newswire) -6.22%
Sep-18-23 05:00PM TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination (PR Newswire) +34.29% -17.25%
Aug-18-23 04:30PM TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination (PR Newswire)
Jul-18-23 04:30PM TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination (PR Newswire)
Jul-12-23 07:00AM TradeUP Acquisition Corp. Announces Meeting Date for Stockholders to Approve the Business Combination with Estrella Biopharma, Inc. and Liquidation of Investments Held in the Trust Account into Cash (PR Newswire)
NUTX - Nutex Health Inc - Stock Price Chart
TickerNUTX [NASD]
CompanyNutex Health Inc
CountryUSA
IndustryHealth Information Services
Market Cap127.71MEPS (ttm)-8.38
P/E-EPS this Y86.67%
Forward P/E109.52EPS next Y116.43%
PEG-EPS past 5Y80.99%
P/S0.46EPS next 5Y-
P/B3.00EPS Q/Q93.86%
Dividend-Sales Q/Q29.12%
Insider Own42.83%Inst Own5.31%
Insider Trans4.61%Inst Trans-
Short Float4.38%EarningsAug 08/a
Analyst Recom1.00Target Price45.00
Avg Volume65.12K52W Range4.16 - 45.00
Aug-26-24 05:30AM NUTEX HEALTH OPENS POST FALLS ER & HOSPITAL, ITS FIRST HOSPITAL IN IDAHO (PR Newswire) +11.84%
Aug-08-24 04:45PM NUTEX HEALTH REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2024 FINANCIAL RESULTS (PR Newswire) +27.85%
Aug-05-24 07:26PM NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL (PR Newswire)
Jul-29-24 05:30AM NUTEX HEALTH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE (PR Newswire) +7.24%
Jul-15-24 08:34AM Nutex Health Hospitals Prove Patient Satisfaction with Nine Awards and Honors Earned in Q2 (PR Newswire) +17.82%
Jul-08-24 07:41AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -7.37%
Jun-27-24 04:30PM NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT (PR Newswire) +7.88%
Jun-19-24 05:30AM NUTEX HEALTH ANNOUNCES THAT IT HAS OBTAINED APPROVAL FROM ITS SHAREHOLDERS TO EFFECT A REVERSE STOCK SPLIT (PR Newswire)
May-24-24 04:45PM NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK. (PR Newswire) -5.91%
May-11-24 08:40AM Nutex Health, Inc. (NASDAQ:NUTX) Q1 2024 Earnings Call Transcript (Insider Monkey)
EUDA - Euda Health Holdings Limited - Stock Price Chart
TickerEUDA [NASD]
CompanyEuda Health Holdings Limited
CountrySingapore
IndustryHealth Information Services
Market Cap83.99MEPS (ttm)-0.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S29.89EPS next 5Y-
P/B-EPS Q/Q-563.70%
Dividend-Sales Q/Q-
Insider Own48.67%Inst Own3.56%
Insider Trans0.00%Inst Trans0.43%
Short Float0.10%Earnings-
Analyst Recom-Target Price-
Avg Volume66.53K52W Range0.60 - 4.97
Aug-21-24 07:00AM Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now (GlobeNewswire) +6.55%
Aug-20-24 07:00AM Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now (GlobeNewswire)
May-08-24 08:44AM EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia (GlobeNewswire) +12.57%
May-06-24 05:00PM EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health (GlobeNewswire) +5.59% -7.41%
Jan-16-24 06:15PM EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Markets Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire) -5.03%
05:29PM EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire)
Oct-05-23 09:00AM EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc. (GlobeNewswire) +7.74%
Sep-22-23 08:00AM EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Markets Continued Listing Requirements (GlobeNewswire)
Aug-14-23 08:15AM EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement (GlobeNewswire)
Aug-04-23 08:30AM EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire)
1⋯89101112131415161718⋯20
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.